ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Headache,Headaches NEC,Headaches,Nerv,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Headache,Headaches NEC,Headaches,Nerv,N
3,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
3,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
4,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
5,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Headache,Headaches NEC,Headaches,Nerv,N
6,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
7,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
8,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
8,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
9,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
9,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
10,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
10,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
10,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
11,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
11,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
11,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
12,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
15,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
16,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
16,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
16,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
16,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Glycosylated haemoglobin decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
17,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
18,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,3,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
18,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
20,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
20,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
20,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,5,Headache,Headaches NEC,Headaches,Nerv,N
20,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
20,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
21,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
22,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
23,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
23,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
23,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
23,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
25,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
26,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
26,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
27,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
28,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
28,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
29,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
29,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
29,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
31,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
31,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
31,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
31,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
31,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
32,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
32,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
32,3,Aortic stenosis,Aortic necrosis and vascular insufficiency,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
32,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
33,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
33,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
34,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
35,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
35,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
36,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
36,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
37,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
37,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
39,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
40,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
41,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
41,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
42,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
43,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
43,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
44,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
46,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
47,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
47,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
48,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
49,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
49,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
50,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
50,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
50,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
51,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
52,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
53,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
54,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
54,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
54,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
55,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
56,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
56,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
56,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
56,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
58,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
58,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
61,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
62,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
62,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
65,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
66,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
67,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
67,2,Headache,Headaches NEC,Headaches,Nerv,N
67,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
68,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
68,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
68,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
68,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
69,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
69,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
70,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
70,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
71,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
72,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
73,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
74,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
74,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
74,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
74,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
74,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
74,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
75,2,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
75,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
75,4,Periarthritis,Joint related disorders NEC,Joint disorders,Musc,N
76,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
77,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
77,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
77,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
78,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
78,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
78,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
79,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
79,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
79,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
80,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
81,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
81,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
82,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
82,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
82,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
82,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
83,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,2,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
84,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
84,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
85,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
86,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
86,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
87,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
87,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
89,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
89,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
90,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
90,2,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
91,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
91,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
92,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
93,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
94,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
94,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
95,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
96,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
97,1,Headache,Headaches NEC,Headaches,Nerv,N
98,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
98,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
99,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
100,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
100,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
102,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
102,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
103,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
103,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
103,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
104,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
104,4,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
104,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
105,2,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
106,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
106,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
106,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
107,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
107,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
107,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
108,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
108,2,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
109,1,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
110,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
111,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
112,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
113,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
113,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
114,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
114,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
115,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
116,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
117,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
117,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
117,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
118,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
118,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
118,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
119,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
120,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
120,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
120,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
120,4,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
121,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
121,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
122,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
122,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
123,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
124,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
124,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
124,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
126,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
127,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
129,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
129,2,Headache,Headaches NEC,Headaches,Nerv,N
129,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
130,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
130,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
130,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
131,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
131,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
131,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
131,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
133,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
134,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
134,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
134,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
135,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
135,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
135,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
135,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
135,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
136,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
136,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
136,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
136,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,1,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
137,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
138,1,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
139,1,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
139,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
140,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
141,2,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
141,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
141,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
141,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
141,7,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
142,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
143,1,Blood ketone body,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
143,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
143,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
143,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
144,2,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
145,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
146,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
147,1,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
147,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
147,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
148,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
148,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
149,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
149,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
149,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
149,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
150,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
150,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
152,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
152,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
153,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
153,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
154,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
155,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
155,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
156,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
156,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
157,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
157,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
157,3,Retinopathy proliferative,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
157,4,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
157,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
158,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
159,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
160,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
161,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
161,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
162,1,Parotid gland enlargement,Salivary gland enlargements,Salivary gland conditions,Gastr,N
162,2,Salivary gland pain,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
163,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
164,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
165,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
166,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
166,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
166,3,Diabetic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
166,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
166,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
167,2,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
168,1,Headache,Headaches NEC,Headaches,Nerv,N
168,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
168,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
169,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
169,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
169,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
169,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
169,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
169,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
170,1,Urticaria papular,Urticarias,Angioedema and urticaria,Skin,N
171,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
171,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
171,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
171,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
171,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
173,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
173,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
173,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
174,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
175,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
176,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
176,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
176,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
176,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
176,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
176,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
176,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
176,8,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
176,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
176,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
178,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
178,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
179,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
179,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
179,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
180,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
181,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
182,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
183,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
184,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
185,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
186,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
186,2,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
187,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
188,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
188,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
190,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
190,2,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
190,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
190,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
191,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
192,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
193,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
194,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
194,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
194,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
195,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
195,2,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
195,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
196,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
196,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
197,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
198,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
199,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
199,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
200,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
200,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
201,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
202,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
203,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
204,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
204,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
205,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
206,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
206,2,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
207,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
207,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
207,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
207,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
207,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
207,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
208,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
208,2,Migraine,Migraine headaches,Headaches,Nerv,N
209,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
209,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
209,3,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
210,1,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
210,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
210,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
210,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
210,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
210,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
211,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
211,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
211,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
212,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
212,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
212,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
212,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
212,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
213,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
214,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
215,1,Koebner phenomenon,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
215,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
216,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
217,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
218,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
218,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
218,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
219,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
219,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
220,1,Headache,Headaches NEC,Headaches,Nerv,N
220,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
222,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
222,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
223,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
223,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
223,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
223,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
223,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
224,1,Multiple congenital abnormalities,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
224,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
225,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
225,2,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
225,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
226,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
227,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
227,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
227,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
228,1,Lymph node pain,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
228,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
228,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
228,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
229,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
229,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
229,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
229,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
230,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
230,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
230,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
230,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
230,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
231,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
231,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
231,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
231,4,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
231,5,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
231,6,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
231,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
231,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
231,9,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
231,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
231,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
231,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
232,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
233,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
234,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
234,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
234,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
234,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
234,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
235,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
236,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
236,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
237,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
237,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
237,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
238,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
239,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
240,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
240,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
240,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
240,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
242,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
242,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
242,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
243,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
243,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
243,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
243,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
244,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
244,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
245,1,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
246,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
247,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
248,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
249,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
250,1,Headache,Headaches NEC,Headaches,Nerv,N
250,2,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
251,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
251,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
252,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
253,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
253,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
253,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
253,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
253,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
253,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
254,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
254,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
254,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
254,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
254,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
256,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
257,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
257,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
258,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
259,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
259,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
260,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
261,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
261,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
262,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
262,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
262,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
263,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
264,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
264,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
265,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
266,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
266,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
267,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
267,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
267,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
268,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
269,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
269,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
269,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
270,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
270,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
271,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
272,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
273,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
274,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
274,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
275,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
275,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
276,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
277,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
277,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
278,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
278,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
280,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
280,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
281,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
282,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
283,1,Amylase abnormal,Digestive enzymes,Gastrointestinal investigations,Inv,N
283,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
284,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
284,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
286,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
287,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
288,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
288,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
289,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
289,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
289,3,Headache,Headaches NEC,Headaches,Nerv,N
289,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
289,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
290,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
291,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
292,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
292,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
292,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
293,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
293,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
293,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
293,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
294,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
294,3,Headache,Headaches NEC,Headaches,Nerv,N
294,4,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
294,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
294,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
295,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
295,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
295,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
295,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
295,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
295,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
296,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
296,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
297,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
297,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,3,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
298,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
298,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
299,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
300,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
301,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
301,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
302,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
303,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
303,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
304,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
305,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
306,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
307,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
307,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
307,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
308,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
309,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
309,2,Pancreatic enzymes increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
309,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
310,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
311,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
312,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
313,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
313,2,Fluid imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
313,3,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
313,4,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
313,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
313,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
313,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
313,9,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
313,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
314,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
314,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
315,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
316,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
317,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
317,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
317,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
317,4,Headache,Headaches NEC,Headaches,Nerv,N
317,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
317,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
318,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
318,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
319,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
319,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
319,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
319,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
319,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
320,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
320,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
321,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
322,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
322,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
322,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
323,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
323,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
324,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
324,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
324,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
325,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
325,2,Headache,Headaches NEC,Headaches,Nerv,N
325,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
326,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
326,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
326,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
326,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
326,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
326,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
326,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
326,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
326,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
326,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
327,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
328,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
328,2,Headache,Headaches NEC,Headaches,Nerv,N
328,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
329,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
329,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
329,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
329,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
329,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
330,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
330,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
331,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
331,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
331,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
331,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
332,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
333,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
333,2,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
333,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
334,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
334,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
334,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
335,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
336,1,Headache,Headaches NEC,Headaches,Nerv,N
337,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
337,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
338,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
338,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
338,3,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
338,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
339,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
340,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
340,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
341,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
341,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
341,3,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
341,4,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
342,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
342,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
342,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
342,4,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
342,5,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
343,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
343,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
343,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
344,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
345,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
345,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
345,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
345,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
346,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
346,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
346,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
347,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
348,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
348,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
348,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
348,4,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
349,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
350,1,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
351,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
351,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
352,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
353,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
353,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
354,1,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
354,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
354,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
355,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
356,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
357,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
357,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
357,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
358,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
359,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
359,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
361,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
361,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
361,3,Headache,Headaches NEC,Headaches,Nerv,N
361,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
361,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
361,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
361,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
361,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
362,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
362,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
363,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
363,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
363,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
364,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
364,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
364,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
365,1,Gingival discolouration,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
365,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
365,3,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
366,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
367,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
368,1,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
368,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
368,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
369,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
370,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
370,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
371,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
371,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
372,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
373,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
374,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
375,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
375,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
375,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
376,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
377,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
377,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
378,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
378,2,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
378,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
378,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
380,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
381,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
381,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
382,1,Cranial nerve disorder,Cranial nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
382,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
382,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
382,4,Meningeal neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
383,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
384,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
385,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
386,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
386,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
386,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
387,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
387,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
387,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
388,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
388,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
388,3,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
388,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
389,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
390,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
390,2,Glycosylated haemoglobin decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
390,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
390,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
391,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
391,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
392,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
392,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
392,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
393,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
394,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
394,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
395,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
396,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
396,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,3,Migraine,Migraine headaches,Headaches,Nerv,N
397,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
398,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
398,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
399,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
399,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
399,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
400,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
401,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
402,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
402,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
403,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
403,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
403,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
403,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
404,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
404,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
405,1,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
405,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
405,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
405,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
405,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
405,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
406,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
406,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
406,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
406,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
407,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
408,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
408,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
408,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
408,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
408,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
409,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
410,1,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
411,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
412,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
413,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
413,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
414,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
415,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
416,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
417,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
418,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
418,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
418,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
419,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
420,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
421,1,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
422,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
423,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
423,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
423,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
423,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
423,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
424,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
424,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
424,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
425,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
426,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
426,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
426,3,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
426,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
426,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
427,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
427,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
428,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
429,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
429,2,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
429,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
429,4,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
429,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
429,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
429,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
429,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
430,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
430,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
431,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
432,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
433,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
433,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
434,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
435,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
435,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
436,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
436,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
437,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
437,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
437,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
437,4,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
437,5,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
437,6,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
437,7,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
437,8,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
437,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
437,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
437,11,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
437,12,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
437,13,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
437,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
437,15,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
438,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
438,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
439,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
440,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
441,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
442,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
442,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
442,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
442,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
442,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
443,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
443,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
443,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
443,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
444,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
445,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
446,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
447,1,Benign neoplasm,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
448,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
448,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
449,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
449,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
450,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
451,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
451,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
452,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
453,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
454,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
455,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
456,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
456,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
457,1,Congenital intestinal malformation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
457,2,Intestinal malrotation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
458,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
458,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
458,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
459,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
459,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
459,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
460,1,Guttate psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
461,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
461,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
461,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
461,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
462,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
463,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
464,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
464,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
465,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
465,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
465,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
466,1,Salpingo-oophorectomy bilateral,Fallopian tube therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
467,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
468,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
468,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
469,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
469,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
469,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
470,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
470,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
470,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
471,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
471,2,Headache,Headaches NEC,Headaches,Nerv,N
471,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
472,1,Headache,Headaches NEC,Headaches,Nerv,N
472,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
474,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
474,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
475,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
475,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
475,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
476,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
476,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
477,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
478,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
478,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
479,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
480,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
480,2,Adenocarcinoma gastric,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
480,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
480,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
481,1,Headache,Headaches NEC,Headaches,Nerv,N
481,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
482,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
482,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
482,3,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
483,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
483,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
484,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
484,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
485,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
485,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
485,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
485,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
486,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
487,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
487,2,Portal pyaemia,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
487,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
488,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
488,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
488,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
488,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
488,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
488,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
489,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
489,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
491,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
492,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
492,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
493,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
493,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
493,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
493,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
493,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
494,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
494,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
495,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
496,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
496,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
497,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
497,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
498,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
498,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
499,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
499,2,Headache,Headaches NEC,Headaches,Nerv,N
499,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
499,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
499,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
499,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
500,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
500,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
500,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
501,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
501,2,Headache,Headaches NEC,Headaches,Nerv,N
501,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
501,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
502,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
503,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
503,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
504,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
504,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
505,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
506,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
506,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
506,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
506,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
507,1,Headache,Headaches NEC,Headaches,Nerv,N
507,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
508,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
508,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
509,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
509,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
509,3,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
509,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
509,5,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
509,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
510,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
510,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
511,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
511,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
511,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
512,2,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
513,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
514,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
515,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
516,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
516,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
517,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
517,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
518,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
519,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
520,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
520,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
520,3,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
521,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
521,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
522,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
523,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
524,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
524,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
525,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
525,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
525,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
525,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
525,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
525,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
526,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
527,1,Headache,Headaches NEC,Headaches,Nerv,N
528,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
528,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
528,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
528,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
529,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
530,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
530,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
530,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
531,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
531,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
531,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
531,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
532,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
532,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
532,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
533,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
533,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
534,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
535,1,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
536,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
536,2,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
537,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
537,2,Glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
537,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
538,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
538,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
539,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
539,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
540,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
541,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
541,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
541,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
541,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
541,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
541,6,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
541,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
542,1,Abnormal sleep-related event,Parasomnias,Sleep disorders and disturbances,Psych,N
543,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
544,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
544,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
544,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
546,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
547,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
547,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
547,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
548,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
548,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
549,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
550,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
551,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
551,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
552,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
553,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
554,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
554,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
554,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
554,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
554,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
554,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
555,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
555,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
556,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
556,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
556,3,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
556,4,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
557,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
557,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
557,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
558,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
558,2,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
559,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
560,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
561,1,Benign pancreatic neoplasm,Gastrointestinal neoplasms benign NEC,Gastrointestinal neoplasms benign,Neopl,N
562,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
562,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
562,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
563,1,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
563,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
563,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
564,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
564,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
564,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
565,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
565,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
566,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
566,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
567,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
568,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
569,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
570,1,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
570,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
571,1,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
572,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
572,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
572,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
573,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
573,2,Gastric varices,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
573,3,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
574,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
575,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
576,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
577,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
577,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
578,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
579,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
579,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
579,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
579,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
580,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
581,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
581,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
582,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
583,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
583,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
583,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
584,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
584,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
584,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
584,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
584,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
585,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
585,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
585,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
586,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
586,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
587,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
587,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
588,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
588,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
588,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
589,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
590,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
591,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
592,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
593,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
594,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
595,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
596,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
596,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
596,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
596,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
596,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
597,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
597,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
598,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
599,1,Headache,Headaches NEC,Headaches,Nerv,N
600,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
600,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
601,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
601,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
602,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
602,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
603,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
603,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
604,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
605,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
606,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
607,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
608,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
609,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
609,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
610,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
610,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
611,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
612,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
613,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
614,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
615,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
615,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
615,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
615,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
615,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
616,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
617,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
617,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
617,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
618,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
618,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
618,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
618,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
618,5,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
618,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
618,7,Peak expiratory flow rate decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
618,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
619,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
619,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
620,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
621,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
622,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
622,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
624,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
625,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
626,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
627,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
628,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
628,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
629,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
629,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
630,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
631,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
632,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
633,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
633,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
633,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
633,4,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
634,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
634,2,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
634,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
634,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
634,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
635,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
636,1,Colorectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
637,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
637,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
637,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
637,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
637,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
638,1,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
639,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
639,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
640,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
640,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
641,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
641,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
641,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
641,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
641,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
642,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
642,2,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
642,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
643,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
644,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
644,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
644,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
644,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
645,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
645,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
646,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
647,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
647,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
648,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
648,2,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
649,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
650,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
650,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
651,1,Headache,Headaches NEC,Headaches,Nerv,N
652,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
652,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
652,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
652,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
653,1,Headache,Headaches NEC,Headaches,Nerv,N
654,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
655,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
656,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
657,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
657,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
657,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
659,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
659,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,1,Headache,Headaches NEC,Headaches,Nerv,N
661,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
661,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
662,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
663,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
663,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
663,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
663,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
664,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
665,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
665,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
665,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
666,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
666,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
666,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
667,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
667,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
667,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
668,1,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
669,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
669,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
669,3,Headache,Headaches NEC,Headaches,Nerv,N
669,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
669,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
669,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
670,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
670,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
671,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
671,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
672,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
672,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
672,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
673,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
673,2,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
674,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
674,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
674,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
675,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
676,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
676,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
676,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
677,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
677,2,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
678,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
679,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
679,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
679,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
680,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
681,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
682,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
683,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
683,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
684,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
684,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
685,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
685,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
686,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
687,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
688,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
688,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
689,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
690,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
690,2,Malignant peritoneal neoplasm,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
691,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
692,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
692,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
693,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
694,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
694,2,Sinus congestion,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
695,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
696,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
697,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
697,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
697,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
698,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
699,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
700,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
700,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
700,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
700,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
701,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
702,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
702,2,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
702,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
702,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
703,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
703,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,3,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
703,4,Product contamination physical,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
704,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
704,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
705,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
705,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
705,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
705,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
706,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
706,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
707,1,Gouty arthritis,Crystal arthropathic disorders,Joint disorders,Musc,N
707,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
708,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
708,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
708,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
708,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
709,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
709,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
710,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
711,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
712,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
713,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
713,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
713,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
714,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
715,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
716,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
716,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
716,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
716,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
716,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
716,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
716,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
717,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
717,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
718,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
719,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
719,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
719,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
720,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
720,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
721,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
722,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
722,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
723,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
723,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
725,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
725,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
725,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
725,4,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
725,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
726,1,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
727,1,Thyroid mass,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
728,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
729,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
729,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
729,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
729,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
730,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
730,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
731,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
732,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
733,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
734,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
735,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
735,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
735,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
735,4,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
735,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
736,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
736,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
736,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
736,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
738,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
738,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
738,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
738,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
739,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
740,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
740,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
740,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
740,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
741,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
741,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
742,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
743,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
743,2,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
743,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
743,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
744,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
744,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
745,1,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
746,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
746,2,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
746,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
746,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
747,1,Adjustment disorder with depressed mood,Adjustment disorders,Adjustment disorders (incl subtypes),Psych,N
747,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
747,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
747,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
747,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
747,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
748,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
748,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
748,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
749,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
749,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
750,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
750,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
751,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
751,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
751,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
752,1,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
753,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
754,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
754,2,Autoimmune pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
754,3,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
754,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
754,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
754,6,Faecal elastase concentration decreased,Digestive enzymes,Gastrointestinal investigations,Inv,N
754,7,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
754,8,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
755,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
755,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
755,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
756,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
756,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
757,1,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
757,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
757,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
757,4,Cholangitis acute,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
757,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
757,6,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
758,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
759,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
760,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
760,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
761,1,Pica,Eating disorders NEC,Eating disorders and disturbances,Psych,N
762,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
762,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
763,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
764,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
765,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
765,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
765,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
766,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
766,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
767,1,Blood cholesterol abnormal,Cholesterol analyses,Lipid analyses,Inv,N
767,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
767,3,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
767,4,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
767,5,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
767,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
767,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
767,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
767,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
768,1,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
769,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
769,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
769,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
769,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
769,5,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
769,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
770,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
771,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
771,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
772,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
772,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
772,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
773,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
773,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
773,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
773,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
774,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
775,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
775,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
775,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
776,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
777,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
777,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
778,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
778,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
778,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
779,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
779,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
779,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
780,1,Androgenetic alopecia,Alopecias,Skin appendage conditions,Skin,N
781,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
781,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
781,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
782,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
783,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
783,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
783,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
783,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
783,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
784,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
784,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
784,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
785,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
785,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
786,1,Cardiac perforation,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
786,2,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,N
787,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
787,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
787,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,1,Headache,Headaches NEC,Headaches,Nerv,N
788,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
788,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
788,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
789,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
789,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
790,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
790,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
790,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
790,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
791,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
791,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
791,3,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
791,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
791,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
792,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
792,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
793,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
793,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
794,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
794,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
794,3,Lip haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
794,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
794,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
795,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
796,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
797,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
798,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
798,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
798,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
799,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
800,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
801,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
801,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
801,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
802,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
802,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
802,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
803,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
803,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
804,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
805,1,Headache,Headaches NEC,Headaches,Nerv,N
805,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
805,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
805,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
805,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
805,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
806,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
806,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
807,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
808,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
809,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
810,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
810,2,Headache,Headaches NEC,Headaches,Nerv,N
810,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
811,1,Electrocardiogram T wave inversion,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
811,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
812,1,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
813,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
813,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
813,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
813,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
814,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
814,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
815,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
815,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
815,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
816,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
817,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
817,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
817,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
817,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
818,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
819,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
819,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
819,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
819,4,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
819,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
819,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
820,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
821,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
822,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
822,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
822,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
822,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
822,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
822,6,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
823,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
823,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
823,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
824,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
825,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
825,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
826,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
826,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
826,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
826,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
827,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
827,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
827,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
828,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
828,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
828,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
828,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
828,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
828,6,Headache,Headaches NEC,Headaches,Nerv,N
828,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
828,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
828,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
828,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
828,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
829,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
829,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
830,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
831,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
832,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
832,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
833,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
833,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
833,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
833,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
834,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
834,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
834,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
834,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
834,5,Glycosylated haemoglobin abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
834,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
834,7,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
834,8,Hyperphagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
834,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
834,10,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
834,11,Microalbuminuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
834,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
834,13,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
834,14,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
834,15,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
834,16,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
834,17,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
835,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
835,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
835,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
836,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
836,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
836,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
836,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
837,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
837,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
837,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
838,1,Bile duct adenocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
839,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
839,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
840,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
841,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
842,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
842,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
842,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
842,4,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
843,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
843,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
843,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
843,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
843,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
844,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
844,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
844,3,High density lipoprotein decreased,Cholesterol analyses,Lipid analyses,Inv,N
844,4,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
845,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
845,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
845,3,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
845,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
845,5,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
845,6,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
845,7,Headache,Headaches NEC,Headaches,Nerv,N
845,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
845,9,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
845,10,Low density lipoprotein increased,Cholesterol analyses,Lipid analyses,Inv,N
845,11,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
845,12,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
845,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
846,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
846,2,High density lipoprotein decreased,Cholesterol analyses,Lipid analyses,Inv,N
846,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
847,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
847,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
847,3,Fibromyalgia,Muscle pains,Muscle disorders,Musc,N
847,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
847,5,Headache,Headaches NEC,Headaches,Nerv,N
847,6,Hypoglycaemia unawareness,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
847,7,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
848,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
848,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
848,3,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
848,4,Headache,Headaches NEC,Headaches,Nerv,N
848,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
848,6,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
848,7,Osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
849,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
849,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
850,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
850,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
850,3,Headache,Headaches NEC,Headaches,Nerv,N
850,4,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
851,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
851,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
851,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
851,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
851,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
853,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
854,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
854,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
854,3,Tongue dry,Tongue signs and symptoms,Tongue conditions,Gastr,N
855,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
855,2,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
855,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
856,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
856,2,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
857,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
857,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
858,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
858,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
859,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
859,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
860,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
860,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
860,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
861,1,Headache,Headaches NEC,Headaches,Nerv,N
861,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
862,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
862,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
862,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
863,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
863,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
864,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
864,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
864,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
864,4,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
864,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
864,6,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
865,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
866,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
866,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
866,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
866,4,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
867,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
868,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
868,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
869,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
870,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
870,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
871,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
871,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
872,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
872,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
873,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
874,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
874,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
875,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
876,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
876,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
877,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
878,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
879,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
880,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
880,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
880,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
880,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
881,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
881,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
882,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
883,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
883,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
883,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
883,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
884,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
884,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
885,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
885,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
885,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
885,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
885,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
885,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
886,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
887,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
888,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
888,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
889,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
890,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
890,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
890,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
891,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
891,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
891,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
892,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
892,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
893,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
894,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
894,2,Thirst decreased,Feelings and sensations NEC,General system disorders NEC,Genrl,N
895,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
896,1,Headache,Headaches NEC,Headaches,Nerv,N
897,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
898,1,Benign neoplasm of thyroid gland,Thyroid neoplasms benign,Endocrine neoplasms benign,Neopl,N
899,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
900,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
901,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
902,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
903,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
903,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
903,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
903,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
903,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
903,6,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
903,7,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
903,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
904,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
905,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
905,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
905,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
905,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
905,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
905,6,Injection site injury,Injection site reactions,Administration site reactions,Genrl,N
905,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
906,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
907,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
908,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
908,2,Headache,Headaches NEC,Headaches,Nerv,N
908,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
908,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
908,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
909,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
909,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
910,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
910,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
910,3,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
911,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
911,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
911,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
912,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
912,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
913,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
913,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
913,3,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
913,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
913,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
913,6,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
913,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
914,1,Granuloma,Inflammations,General system disorders NEC,Genrl,N
914,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
915,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
916,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
916,2,Thyroid mass,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
917,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
917,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
918,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
918,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
918,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
919,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
920,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
920,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
920,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
920,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
920,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
920,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
920,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
920,8,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
921,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
921,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
921,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
921,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
922,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
922,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
922,3,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
922,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
922,5,Intracranial aneurysm,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
922,6,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
922,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
922,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
922,9,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
922,10,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
924,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
925,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
926,1,Endometrial cancer,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
927,1,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
927,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
928,1,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
929,1,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
930,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
931,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
931,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
931,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
931,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
932,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
932,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
932,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
933,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
933,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
933,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
933,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
934,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
935,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
936,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
936,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
937,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
938,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
939,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
939,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
939,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
940,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
941,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
941,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
942,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
942,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
943,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
943,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
943,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
943,4,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
944,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
944,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
945,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
945,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
945,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
945,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
946,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
946,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
946,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
946,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
947,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
947,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
948,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
948,2,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
949,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
949,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
949,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
950,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
950,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
950,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
951,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
952,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
952,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
952,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
952,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
952,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
953,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
953,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
953,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
953,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
954,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
955,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
956,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
957,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
958,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
959,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,Y
959,2,Congenital aortic stenosis,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
959,3,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
960,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
960,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
960,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
961,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
961,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
961,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
962,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
963,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
963,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
964,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
964,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
965,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
965,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
965,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
965,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
965,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
966,1,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
967,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
967,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
968,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
968,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
968,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
969,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
969,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
970,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
971,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
972,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
972,2,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
972,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
972,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
973,1,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
974,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
974,2,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
975,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
976,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
976,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
977,1,Headache,Headaches NEC,Headaches,Nerv,N
977,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
978,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
978,2,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
978,3,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
979,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
979,2,Thyroid mass,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
980,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
980,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
981,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
982,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
983,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
983,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
984,1,Carbohydrate antigen 19-9 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
985,1,Bile duct cancer,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
985,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
986,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
986,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
987,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
988,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
988,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
988,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
988,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
988,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
989,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
989,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
990,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
991,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
991,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
991,3,Seizure like phenomena,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
992,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
992,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
992,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
992,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
993,1,Headache,Headaches NEC,Headaches,Nerv,N
993,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
994,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
994,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
994,3,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
995,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
996,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
996,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
997,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
997,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
997,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
997,4,Headache,Headaches NEC,Headaches,Nerv,N
997,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
997,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
998,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
998,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
998,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
999,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1000,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1000,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1001,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1002,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1003,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1003,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1004,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1004,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1004,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1004,4,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1005,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1006,1,Cystadenocarcinoma pancreas,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1006,2,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1007,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1007,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1007,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1007,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1007,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1007,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1007,7,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1008,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1009,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1010,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1010,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1011,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1011,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1012,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1012,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1013,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1013,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1014,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1015,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1015,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1015,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1016,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1016,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1016,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1016,4,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
1016,5,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1017,1,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1018,1,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1019,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1019,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1019,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1019,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1020,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1020,2,Renal ischaemia,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1021,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1021,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1021,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1022,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1022,2,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1023,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1023,2,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1023,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1023,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1023,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1024,1,Goitre,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1025,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1026,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1027,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1027,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1027,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1027,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1028,1,Arrhythmic storm,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1029,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1030,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1030,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1030,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1030,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1030,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1030,6,Phobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1031,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1031,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1032,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1032,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1032,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1032,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1032,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1033,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1033,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1033,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1033,4,Food intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
1033,5,Headache,Headaches NEC,Headaches,Nerv,N
1033,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1033,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1033,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1033,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1033,10,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1034,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1034,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1034,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1034,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1035,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1035,2,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1036,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1036,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1037,1,Migraine,Migraine headaches,Headaches,Nerv,N
1038,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1038,2,Hypoglycaemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1038,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1039,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1040,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1041,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1041,2,Headache,Headaches NEC,Headaches,Nerv,N
1041,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1041,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1041,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1042,1,Headache,Headaches NEC,Headaches,Nerv,N
1042,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1042,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1042,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1042,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1042,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1043,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1044,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1044,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1045,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1046,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1047,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1047,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1047,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1048,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1049,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1049,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1050,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1050,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1050,3,Faecal vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1051,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1052,1,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1053,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1054,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1054,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1054,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1054,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1055,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1055,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1055,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1056,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1057,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1057,2,Headache,Headaches NEC,Headaches,Nerv,N
1057,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1058,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1058,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1059,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1059,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1059,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1059,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1060,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1060,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1060,3,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1060,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1061,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1062,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1063,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1063,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1063,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1063,4,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1063,5,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1063,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1063,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1064,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1065,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1065,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1066,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1067,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1067,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1068,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1068,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1068,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1068,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1068,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1068,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1068,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1069,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1070,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1071,1,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1072,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1072,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1072,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1072,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1073,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1074,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1075,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1075,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1076,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1076,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1077,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1078,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1079,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1080,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1081,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1081,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1082,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1082,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1083,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1084,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1085,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1086,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1086,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1086,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1086,4,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1087,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1088,1,Carcinoid tumour of the pancreas,Carcinoid tumours,Endocrine neoplasms malignant and unspecified,Neopl,N
1089,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1089,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1090,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1090,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1090,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1090,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1090,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1090,6,Gastric dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1090,7,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1090,8,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1090,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1090,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1091,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1092,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1092,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1092,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1092,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1093,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1094,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1095,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
1096,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1097,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1098,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1099,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1100,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1100,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
1100,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1101,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1101,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1101,3,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1101,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1101,5,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1101,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1101,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1102,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1102,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1102,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1103,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1104,1,Pancreatic pseudocyst,Cystic pancreatic disorders,Exocrine pancreas conditions,Gastr,N
1105,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1105,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1106,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1107,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1107,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1108,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1108,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1108,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1109,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1109,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1110,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1111,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1111,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1111,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1112,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1112,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1113,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1114,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1114,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1115,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1115,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1115,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1116,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1117,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1117,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1118,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1118,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1119,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1119,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1120,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1121,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1121,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1121,3,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1122,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
1123,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1123,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1123,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1124,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1124,2,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1124,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1125,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1125,2,Device issue,Device issues NEC,Device issues,Prod,N
1125,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1126,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1126,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1127,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1127,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1128,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1128,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1128,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1128,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1129,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
1130,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1130,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1131,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1131,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1131,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1132,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1133,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1133,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1133,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1134,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1134,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1134,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1135,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1135,2,Aneurysm,Aneurysms and dissections non-site specific,Aneurysms and artery dissections,Vasc,N
1135,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1135,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1135,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1135,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1135,7,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1135,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1135,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1135,10,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1135,11,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1135,12,Precancerous mucosal lesion,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1135,13,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1135,14,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1135,15,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1135,16,Renal cyst,Renal neoplasms,Renal disorders (excl nephropathies),Renal,N
1136,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1137,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1137,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1137,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1137,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1137,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1137,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1137,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1137,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1138,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1138,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1139,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1139,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1140,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1141,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1142,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1143,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1143,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1143,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1144,1,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
1145,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1145,2,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
1145,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1145,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1146,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1146,2,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1147,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1147,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1148,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1148,2,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1149,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1149,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1150,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1150,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1150,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1150,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1150,5,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1151,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1152,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1152,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1152,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1152,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1152,5,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1152,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1152,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1152,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1153,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1153,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1153,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1153,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1154,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1154,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1154,3,Throat lesion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1154,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1155,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1155,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1155,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1155,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1155,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1155,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1156,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1156,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1157,1,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1157,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1157,3,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
1157,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1158,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1158,2,Depressive symptom,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1158,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1158,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1158,5,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
1158,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1158,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1158,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1158,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1159,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1159,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1159,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1160,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1160,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1160,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1161,1,Administration site inflammation,Administration site reactions NEC,Administration site reactions,Genrl,N
1161,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1162,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1163,1,Pancreatic carcinoma metastatic,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1164,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1164,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1164,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1165,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1165,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1166,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1167,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1167,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1167,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1167,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1167,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1168,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1168,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1169,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1169,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1169,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1170,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1171,1,Adenoma benign,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
1171,2,Chronic gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1171,3,Intestinal metaplasia,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1171,4,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
1171,5,Microcytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
1172,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1172,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1173,1,Groin abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1173,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1173,3,Loose tooth,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1173,4,Noninfective gingivitis,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1173,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1174,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1175,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1176,1,Cholangiocarcinoma,Bile duct neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
1176,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1177,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1177,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1177,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1177,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1177,5,Headache,Headaches NEC,Headaches,Nerv,N
1177,6,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1177,7,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1177,8,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1177,9,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1177,10,Soliloquy,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1177,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1177,12,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1178,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1179,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1179,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1179,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1180,1,Gastroenteropancreatic neuroendocrine tumour disease,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
1181,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1182,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1183,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1183,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1183,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1183,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1184,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1184,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1184,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1184,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1184,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1185,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1186,1,Hepatic cancer,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
1186,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1187,1,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1188,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1188,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1189,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1190,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1191,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1191,2,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1191,3,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1191,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1191,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1191,6,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
1192,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1193,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1194,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1194,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1194,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1195,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1195,2,Neuroendocrine tumour,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,Y
1196,1,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1197,1,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1197,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1197,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1198,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1198,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1198,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1199,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1200,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1201,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1202,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1203,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,Y
1204,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1204,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1204,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1205,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1205,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1205,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1205,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1206,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1206,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1207,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1208,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1208,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1208,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1208,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1209,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1210,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1211,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1212,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1213,1,Bezoar,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1214,1,Abdominal wall neoplasm malignant,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1215,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1215,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1215,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1215,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1215,5,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
1215,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1215,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1215,8,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
1215,9,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1215,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1216,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1217,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1217,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1217,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1217,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1218,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1218,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1219,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1219,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1219,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1219,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1220,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1220,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1221,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1222,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1222,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1222,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
1222,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1222,5,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1222,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1223,1,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
1223,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1223,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1224,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1225,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1226,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
1226,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1227,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1227,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1228,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1229,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1229,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1229,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1229,4,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1229,5,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1229,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1229,7,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1229,8,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1229,9,Hepatic hydrothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
1229,10,Hepatorenal syndrome,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1229,11,Hydrothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1229,12,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1229,13,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
1229,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1229,15,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1229,16,Lichen sclerosus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1229,17,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1229,18,Non-alcoholic steatohepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1229,19,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
1229,20,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1229,21,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1229,22,Phimosis,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
1229,23,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1229,24,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1229,25,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1229,26,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1230,1,Headache,Headaches NEC,Headaches,Nerv,N
1231,1,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
1231,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1231,3,Thyroid neoplasm,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
1232,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
1232,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1233,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1233,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1233,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1233,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1234,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1234,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1234,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1234,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1235,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1236,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1236,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1236,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1237,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1237,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1237,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1237,4,Pseudocyst,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1237,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1238,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1238,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1239,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1240,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1241,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1241,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1242,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1243,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1243,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1243,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1244,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1244,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1244,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1244,4,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1245,1,Connective tissue neoplasm,Soft tissue neoplasms malignant and unspecified NEC (excl sarcomas),Soft tissue neoplasms malignant and unspecified,Neopl,N
1246,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1247,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1247,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1248,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1248,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1248,3,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1248,4,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1248,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1248,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1248,7,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1248,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1248,9,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1248,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1249,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1249,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
1249,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
1249,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1250,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1250,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1251,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1251,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1251,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1251,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1251,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1252,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1252,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1252,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1252,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1252,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1252,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1252,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1252,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1252,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1252,10,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1252,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1253,1,Device leakage,Device issues NEC,Device issues,Prod,N
1253,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1253,3,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1254,1,Device leakage,Device issues NEC,Device issues,Prod,N
1254,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1254,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1255,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1256,1,Vaccination site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1256,2,Vaccination site erythema,Vaccination site reactions,Administration site reactions,Genrl,N
1256,3,Vaccination site pruritus,Vaccination site reactions,Administration site reactions,Genrl,N
1256,4,Vaccination site warmth,Vaccination site reactions,Administration site reactions,Genrl,N
1257,1,Abdominal wall haemorrhage,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1257,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1258,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1258,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1258,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1258,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1259,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1259,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1259,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1260,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1260,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1261,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1261,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1262,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1262,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1263,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1263,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1264,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1265,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1266,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1267,1,Device leakage,Device issues NEC,Device issues,Prod,N
1267,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1267,3,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1267,4,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1268,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1268,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1268,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1269,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1269,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1270,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1270,2,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1270,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1270,4,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1270,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1270,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1271,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1271,2,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1271,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1271,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1271,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1271,6,Migraine,Migraine headaches,Headaches,Nerv,N
1271,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1271,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1272,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1272,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1273,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1274,1,Device leakage,Device issues NEC,Device issues,Prod,N
1274,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1275,1,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1275,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1275,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1276,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1277,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1278,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1279,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
